Cancer Diagnostics Conference

• 4D Radiomics in dynamic contrast-enhanced MRI: Prediction of Breast Cancer pathological complete response to neoadjuvant chemotherapy
• Multicancer Early Detection Tests
• Early detection of cancer using cell-free DNA fragment omics
• Development of a predictive model for head and neck cancer risk assessment, encompassing lifestyle parameters, HPV serological markers, and genetic biomarkers
• Deep Learning & Biomarker Panels-Based Platform for Breast Cancer Detection
• Challenges and opportunities in early detection
   

• Learn about innovative devices and procedures for effective and early-stage cancer diagnostics.
• Meet global heads of cancer diagnostics from the industry and Academics.
• Participate in discussions with experts on how technology implementation can be improved
• Attracting and retaining world-class talent
• Resolve common R&D challenges
• Discover the latest technology implementations in the industry
• Discover best-in-class solutions during the workshop sessions
• Interactive panel discussions
• 120+ Professionals Attending
• Case studies presented from leading technology collaborations.

MarketsandMarkets Cancer Diagnostics Conference typically attracts a diverse range of professionals, researchers, and experts from various fields related to cancer diagnosis and treatment. The attendees may include:

1. Oncologists: Medical doctors who specialize in the diagnosis and treatment of cancer.
2. Pathologists: Experts who study tissues, cells, and organs to diagnose diseases, including cancer.
3. Radiologists: Physicians who use medical imaging techniques like X-rays, MRI, and CT scans to detect and diagnose cancer.
4. Clinical Researchers: Professionals involved in cancer clinical trials and research studies.
5. Pharmaceutical Industry Representatives: Professionals from pharmaceutical companies developing cancer diagnostics and treatments.
6. Medical Laboratory Professionals: Individuals working in medical laboratories responsible for analyzing cancer-related samples.
7. Biomedical Scientists: Researchers studying cancer biology, genetics, and molecular mechanisms.
8. Epidemiologists: Experts who study the patterns, causes, and effects of cancer in populations.
9. Genetic Counsellors: Professionals who provide information and support to individuals and families at risk for hereditary cancer.
10. Healthcare Administrators: Professionals responsible for managing cancer care facilities and services.
11. Patient Advocates: Individuals and organizations representing the interests of cancer patients and survivors.
12. Medical Students and Residents: Students and trainees interested in oncology and cancer diagnostics.
13. Healthcare IT Specialists: Professionals working on healthcare information technology solutions for cancer diagnostics and patient management.
14. Medical Device Manufacturers: Companies developing and producing medical devices used in cancer diagnosis.
15. Data Scientists and Bioinformaticians: Experts in data analysis and bioinformatics, crucial for cancer research and diagnostics.
16. Entrepreneurs and Startups: Individuals and companies with innovative technologies and solutions for cancer diagnostics.
17. Academic and Research Institutions: Representatives from universities and research centres conducting cancer-related studies.
18. Investors and Funding Organizations: Individuals and groups interested in investing in cancer research and diagnostic technologies.
19. University/Hospital Departments: Genomics, Proteomics, Oncology, Molecular Biology, Genetics Bioinformatics, Computational Biology, Pharmacogenomics, Pathologists